RSRGVFF (FOXP3 inhibitor P60) is a mixed-type angiotensin-converting enzyme (ACE) inhibitor with blood-brain barrier permeability, boasting an IC50 value of 5.01 µM[1]. RSRGVFF is capable of binding to both active and non-active sites of ACE and its substrate HHL complex, thus reducing the catalytic activity of ACE. RSRGVFF can be further utilized for research on lowering hypertension[1].
Molecular Weight:
867.99
Formula:
C40H61N13O9
Target:
Angiotensin-converting Enzyme (ACE)
Application Notes:
Peptides
* VAT and and shipping costs not included. Errors and price changes excepted
